CoCensys
Executive Summary
William Schary, PhD, named VP-regulatory affairs of the Irvine, Calif.-based CNS drug company. Schary was previously a VP at the contract research firm New Drug Services and, from 1979-82, a reviewing neuropharmacologist at FDA.